LPL and metabolic dysfunction-associated steatotic liver disease: Also, similar to Teratani et al.48, who reported that NAFLD and nonalcoholic steatohepatitis (NASH) patients' livers had significantly greater levels of LPL messenger RNA (mRNA) expression than did healthy subjects' livers.